Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,022.95
(
0.80%
)
US TECH 100
25,476.80
(
1.32%
)
Dow Jones
48,463.72
(
-0.15%
)
Brent Oil
92.66
(
-2.94%
)
Bitcoin
75,056.72
(
1.15%
)
News Focus
News Focus
Post# of 517306
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rayovacAAA

Send PM Follow Ignore
Followers 16
Posts 5838
Boards Moderated 0
Alias Born 07/16/2018

rayovacAAA

Re: Lima4918 post# 246950

Sunday, 04/19/2020 4:15:14 PM

Sunday, April 19, 2020 4:15:14 PM

Post# of 517306
EXACTLY, HAMPEL WAS "DELIGHTED TO JOIN" THE AVXL TEAM BEFORE HE LEFT!!!!!!!!


https://www.anavex.com/anavex-appoints-international-alzheimers-expert-to-scientific-advisory-board/

“I am impressed with Anavex and its potential CNS platform drug, ANAVEX 2-73, which has shown promising interim clinical data from its Phase 2a Alzheimer’s trial,” said Dr. Hampel. “Anavex has also assembled an impressive team of business and scientific leaders, which I am delighted to join.




FACTS ARE NOT FUNNIES EVEN ON SUNDAY!!!!!!!!!!!!
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News